Tops & Flops Stocks
| Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aceragen Inc. | -39.430% | - | - | - | - | - | - |
| Brainstorm Cell | -30.000% | -29.447% | -33.143% | -87.283% | 51.293% | -87.897% | - |
| Endo International | -16.670% | 20.000% | 500.000% | -82.857% | -70.000% | -99.756% | -99.822% |
| Fortress Biotech Inc. | -12.900% | - | - | - | - | - | - |
| ImmunityBio Inc. | -9.860% | 46.091% | 49.480% | 194.252% | 58.347% | -49.404% | - |
| Bellicum Pharmaceuticals Inc. | -9.290% | - | - | - | - | - | - |
| Neos Therapeutics Inc | -8.590% | - | - | - | - | - | - |
| Curis Inc. | -8.090% | - | - | - | - | - | - |
| Durect Corp. | -8.040% | - | - | - | - | - | - |
| Heron Therapeutics Inc. | -7.990% | -16.922% | -15.234% | 0.463% | 38.217% | -85.060% | - |
| Akebia Therapeutics Inc. | -5.910% | -8.197% | -31.787% | 42.201% | 0.341% | -55.789% | - |
| Lexicon Pharmaceuticals Inc. | -5.820% | -4.611% | -34.182% | -33.578% | 4.928% | -67.016% | -72.154% |
| Cumberland Pharmaceuticals | -4.690% | - | - | - | - | - | - |
| SCYNEXIS Inc. | -4.490% | 9.635% | 14.112% | -44.203% | -18.807% | -74.223% | - |
| Spectrum Pharmaceuticals | -4.190% | - | - | - | - | - | - |
| Krystal Biotech | -3.260% | -4.128% | -12.560% | 89.739% | 25.129% | - | - |
| Lumos Pharma Inc. | -3.200% | - | - | - | - | - | - |
| Anavex Life Sciences Corp | -3.170% | -0.867% | -26.537% | -53.548% | -60.447% | -65.700% | 37.200% |
| Eagle Pharmaceuticals Inc | -3.160% | -9.859% | -16.883% | -84.882% | -14.286% | -89.091% | -91.805% |
| Savara Inc. | -3.030% | -5.882% | -6.726% | 152.121% | -2.804% | 163.291% | -56.362% |
| Pieris Pharmaceuticals Inc | -2.980% | - | - | - | - | - | - |
| Acorda Therapeutics Cdt | -2.970% | - | - | - | - | - | - |
| Salarius Pharmaceuticals Inc. | -2.830% | -4.072% | 0.000% | -70.556% | -23.604% | -98.430% | -99.993% |
| XBiotech Inc | -2.740% | -3.947% | 0.690% | 144.966% | 106.215% | -48.555% | -7.431% |
| Adverum Biotechnologies Inc. | -2.650% | - | - | - | - | - | - |